43 min listen
Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy
FromKeeping Current
Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy
FromKeeping Current
ratings:
Length:
49 minutes
Released:
Nov 23, 2023
Format:
Podcast episode
Description
The perioperative therapeutic landscape for early-stage resectable NSCLC is advancing rapidly. Are you up to date? Credit available for this activity expires: 22/11/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998570?ecd=bdc_podcast_libsyn_mscpedu
Released:
Nov 23, 2023
Format:
Podcast episode
Titles in the series (99)
Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams: Did you know that up to 47% of patients taking renin-angiotensin-aldosterone system inhibitors see their therapy discontinued after developing mild or moderate-to-severe hyperkalemia? Credit available for this activity expires: 5/31/24 Earn Credit /... by Keeping Current